71 filings
Page 2 of 4
6-K
pbip wf6o0w
10 Nov 22
Molecular Partners Presents Positive Interim Safety and Mechanistic Data From Ongoing Phase 1 Trial of MP0317 for Treatment of Solid Tumors
8:00am
6-K
gmla05bfi3jvrwqt4i
27 Oct 22
Current report (foreign)
4:01pm
6-K
rdsbvnhgc7e qt7qx
27 Oct 22
Current report (foreign)
4:00pm
6-K/A
nrqbq2 0zkthd32sx
31 Aug 22
Current report (foreign) (amended)
12:28pm
6-K
979fzh2
25 Aug 22
Molecular Partners Reports Corporate Highlights and H1 2022 Financials
4:31pm
EFFECT
472g4j
13 Jul 22
Notice of effectiveness
12:15am
F-3
xayhu sahtzxk
1 Jul 22
Shelf registration (foreign)
9:10am
6-K
uq12gkgljx rb90xyz3
13 Jun 22
Current report (foreign)
6:10am
6-K
62om5899u13p
12 May 22
Current report (foreign)
4:05pm
6-K
c51y9v
26 Apr 22
Molecular Partners to Regain Global Rights for MP0310 from Amgen
4:05pm
6-K
k52x0hw5q t0eodf
26 Apr 22
Molecular Partners Provides Update on Ensovibep Following Novartis Quarterly Earnings Call
2:05pm
6-K
ibpoo4dt3 hz6c2i
14 Apr 22
Molecular Partners Announces Shareholders Approve All Board Proposals at the Annual General Meeting
6:05am
6-K
xicy69ykbaqfzwbr
17 Mar 22
Molecular Partners Publishes Invitation to Annual General Meeting 2022
6:10am
6-K
j6rj5
15 Mar 22
Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
4:30pm
20-F
r0eq47kg7
15 Mar 22
Annual report (foreign)
4:25pm
6-K
q1fl71r
10 Feb 22
Emergency Use Authorization Request for Ensovibep Submitted to the US Food and Drug Administration for the Treatment of COVID-19
6:10am
6-K
iml 1gzh5d3
18 Jan 22
Molecular Partners Finalizes License Agreement with Novartis for Ensovibep for COVID-19
6:10am
6-K
tfhls4
10 Jan 22
Molecular Partners and Novartis Report Positive Topline Data from Phase 2 Study for Ensovibep (MP0420), a DARPin Antiviral Therapeutic for COVID-19
9:18am
6-K
17f62ane0dejf x8mask
15 Dec 21
Current report (foreign)
1:38pm
6-K
9a67yh
14 Dec 21
Molecular Partners Announces Collaboration with Novartis to Develop DARPin-Conjugated Radioligand Therapeutic Candidates for Oncology
6:10am